Group 1 - Beijing Rural Commercial Bank's Economic and Technological Development Zone Branch issued its first "Technology R&D Loan" of over 2.36 million yuan to Beijing Huanuo Tai Biopharmaceutical Technology Co., Ltd., providing crucial funding for vaccine innovation and R&D [1] - The loan will specifically support key aspects of vaccine R&D, including raw material procurement, laboratory equipment upgrades, and team support, addressing the financing challenges faced by biopharmaceutical companies due to a lack of collateral [1][2] - The innovative financing model transforms the company's R&D investment, core patents, and team qualifications into credit assessment criteria, allowing for more flexible financing solutions for technology-driven enterprises lacking tangible assets [2] Group 2 - The "Technology R&D Loan" is part of a broader financial service system aimed at supporting technology innovation, with Beijing Rural Commercial Bank offering a product matrix of 75 financial products covering the entire lifecycle of enterprises [3] - This initiative reflects the bank's commitment to addressing the financing difficulties of biopharmaceutical companies and supporting the real economy and technological innovation [3] - The bank plans to deepen its technological financial innovation practices and enhance its credit product offerings, contributing to the construction of an international technology innovation center in Beijing and the high-quality development of the real economy [3]
236万元"科技研发贷"落地经开区，北京农商银行创新金融模式助力生物医药企业突破融资瓶颈